Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis.

Cells · 2022 · PMC8997427 · PMID 35406670

Europe PMC DOI

hedged sentences

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

did not reach statistical significancep = 0.056so close (0.05 < p ≤ 0.1)

9.8 ± 4.1 ng/mL), although the difference did not reach statistical significance ( p = 0.056).

also in 111,027 other papers

showed a trendno p-value reported

Serum RCN2 levels showed a trend toward association with statin treatment in the CAVA cohort of CAD patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.